Zobrazeno 1 - 10
of 115
pro vyhledávání: '"Carles, Villabona"'
Autor:
Joan Gil, Montserrat Marques-Pamies, Miguel Sampedro, Susan M. Webb, Guillermo Serra, Isabel Salinas, Alberto Blanco, Elena Valassi, Cristina Carrato, Antonio Picó, Araceli García-Martínez, Luciana Martel-Duguech, Teresa Sardon, Andreu Simó-Servat, Betina Biagetti, Carles Villabona, Rosa Cámara, Carmen Fajardo-Montañana, Cristina Álvarez-Escolá, Cristina Lamas, Clara V. Alvarez, Ignacio Bernabéu, Mónica Marazuela, Mireia Jordà, Manel Puig-Domingo
Publikováno v:
Scientific Reports, Vol 12, Iss 1, Pp 1-14 (2022)
Abstract Predicting which acromegaly patients could benefit from somatostatin receptor ligands (SRL) is a must for personalized medicine. Although many biomarkers linked to SRL response have been identified, there is no consensus criterion on how to
Externí odkaz:
https://doaj.org/article/808c6529d3d048e285b130d06f2414e2
Publikováno v:
Medicina Clínica.
Publikováno v:
Medicina Clínica.
Autor:
Miguel Paja-Fano, Fernando Guerrero-Pérez, Juan J. Díez, Diana Ariadel Cobo, José Manuel Cabezas Agrícola, Javier Gavira, I. Peiró, Idoia Genua, Susan M. Webb, Manuel Mateu-Salat, Betina Biagetti, Pedro Iglesias, Antía Fernández Pombo, Mariona Riudavets, Carlos García Gómez, Carles Villabona, Cristina Lamas, Margarita Majem
Publikováno v:
ENDOCRINE-RELATED CANCER
r-IIB SANT PAU. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica Sant Pau
instname
r-IIB SANT PAU. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica Sant Pau
instname
Central adrenal insufficiency (AI) due to isolated adrenocorticotropic hormone (ACTH) deficiency (IAD) has been recently associated with immune checkpoint inhibitor (ICI) therapy. Our aim was to analyze the prevalence, clinical characteristics, and t
Autor:
Pedro Iglesias, Betina Biagetti, Marta Araujo-Castro, Victoria Alcázar, Fernando Guerrero-Pérez, Noelia Rivero, Anna Casteràs, Carlos García Gómez, Belén García Izquierdo, Víctor Viedma Torres, Eider Pascual-Corrales, Isabel Pavón, Carles Villabona, Fernando Cordido, Juan J. Díez
[Abstract] Background: In recent years, dopamine agonists (DAs) have become an attractive therapeutic option to prevent both tumor growth and post-surgical tumor remnant growth in clinically non-functioning pituitary adenoma (NFPA). Aim: To analyze o
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b40d967446a1fd17b7ca680578db3cc8
https://hdl.handle.net/2183/32378
https://hdl.handle.net/2183/32378
Autor:
Nuria Vilarrasa, Fernando Guerrero-Pérez, Noemi Vidal, Juan José Sánchez-Fernández, Carles Villabona
Publikováno v:
Endocrinología, Diabetes y Nutrición. 69:229-231
Autor:
Fernando, Guerrero-Pérez, Noemi, Vidal, Juan José, Sánchez-Fernández, Nuria, Vilarrasa, Carles, Villabona
Publikováno v:
Endocrinología, Diabetes y Nutrición (English ed.). 69:229-231
The recurrent p.( Pro540Ser ) MEN1 genetic variant should be considered nonpathogenic: A case report
Autor:
Teresa Serrano, Fernando Guerrero-Pérez, Mariló Chiara, Carles Villabona, Josep Oriola, Mercedes Robledo, Nuria Valdés
Publikováno v:
American Journal of Medical Genetics Part A. 185:3872-3876
Pheochromocytoma/paraganglioma (Pheo/PGL) associated with pituitary adenoma (PA) is rare in clinical practice, and a common pathogenic mechanism has been suggested owing to the germline pathogenic variants found in some cases. Our aim is to propose a
Autor:
I Lorenzo, Paula Jiménez-Fonseca, M I Del Olmo-García, Ana Custodio, J Á Díaz, Carles Villabona, N Canal, G. de la Cruz, M J Gomez, Alberto Carmona-Bayonas
Publikováno v:
CLINICAL & TRANSLATIONAL ONCOLOGY
r-IIS La Fe. Repositorio Institucional de Producción Científica del Instituto de Investigación Sanitaria La Fe
instname
Dipòsit Digital de la UB
Universidad de Barcelona
Clinical & Translational Oncology
r-IIS La Fe. Repositorio Institucional de Producción Científica del Instituto de Investigación Sanitaria La Fe
instname
Dipòsit Digital de la UB
Universidad de Barcelona
Clinical & Translational Oncology
Purpose To report healthcare resource use and associated costs in controlled versus uncontrolled carcinoid syndrome (CS) in patients with neuroendocrine tumours. Methods A cross-sectional, non-interventional multicentre study was conducted with retro
Autor:
Teresa Serrano, Jose Carlos Ruffinelli, Roger Llatjós, Pedro Iglesias, Ivan Macia, Fernando Guerrero-Pérez, Agustina Pia Marengo, Carles Villabona, I. Peiró, Alex Teulé, Nuria Vilarrasa
Publikováno v:
Reviews in Endocrine and Metabolic Disorders. 22:1041-1056
Knowledge of ectopic Cushing’s syndrome (CS) due to thymic neuroendocrine tumours (NETs) comes from short series or single cases. Our aim is to perform a systematic review using PubMed, Embase, Scopus, Ovid Medline and Biosis Previews of all cases